Software defect, which allows the system to accept erroneous, non-monotonous calibrations for Spline-type assays. Cobas pro integrated solutions is an automated analyzer, intended for…
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
Issues identified: 1) Results vary by Instrument Platform; 2) Calibrator Lot-to-Lot Variability. Issues may lead to delayed or incorrect diagnosis, as well as delay of treatment or…
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
Creatine Kinase (CK) Assay Abnormal calibrations on the cobas c 311/501/502 and COBAS INTEGRA 400 plus Analyzers may lead to erroneous results and misdiagnosis.
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
A complaint investigation revealed that an incorrect behavior relating to the rejection of orders capability of the Host Connectivity Agent (HCA) could occur where the order received from…
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
Software issue resulting in signals and sample test results of Pre-Wash tests being impacted. The following assays are considered impacted by the issue: Anti-HAV2, Anti-HBc IgM, IGF-1,…
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
A potential risk for false negative nitrite results exists when endogenous creatinine levels are 15,000 mg/L and above. No interference of Nitrite results was observed at creatinine levels…
Class IIFDA: TerminatedRoche Diagnostics Operations, Inc.
Under specific circumstances created by the user, the cobas e flow test results could be replaced by an automatic result sent to the lab LIS. This automatic result could be released and…
Class IIFDA: TerminatedRoche Diagnostics Operations, Inc.
Roche received several complaints regarding increased control recovery and discrepant elevated results for the Iron Gen.2 (IRON2) assay on the cobas c311, 501, and 502 analyzers and on the…
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
Recall reason is possible sporadic false negative conventional troponin results. Roche has confirmed an issue with running Elecsys Troponin I/Troponin I STAT and Elecsys proBNP II/proBNP II…
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
Recall reason is possible sporadic false negative conventional troponin results. Roche has confirmed an issue with running Elecsys Troponin I/Troponin I STAT and Elecsys proBNP II/proBNP II…
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
May display Calcium results on the screen with wrong arrow direction which may lead to misinterpretation of results and incorrect medical decision. If the unit for iCa++ is set to mg/dL…
Class IIFDA: TerminatedRoche Diagnostics Operations, Inc.
A software error results in the unintentional removal of the serum-indices flag that would otherwise prevent the release of results. The Cobas Inifinity has an auto-verification feature to…
Class IIFDA: TerminatedRoche Diagnostics Operations, Inc.
Possible Misinterpretation of Displayed Measuring Units from INR to %Quick or Seconds; providing instructions to users for ensuring the meter is displaying INR results
Class IIFDA: TerminatedRoche Diagnostics Operations, Inc.
Possible Misinterpretation of Displayed Measuring Units from INR to %Quick or Seconds; providing instructions to users for ensuring the meter is displaying INR results
Class IIFDA: TerminatedRoche Diagnostics Operations, Inc.
During the subsequent pipetting (1st or 2nd measurement), the residual reagent can sporadically be transferred from the conus into the reaction cuvette and lead to inaccurately low results…
Class IIFDA: TerminatedRoche Diagnostics Operations, Inc.
Potential for Changed Configuration Settings on the cobas 8000 modular analyzer series/cobas pro integrated solutions, may cause incorrect results in several affected parameters. In the…
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
Potential for Changed Configuration Settings on the cobas 8000 modular analyzer series/cobas pro integrated solutions, may cause incorrect results in several affected parameters. In the…
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
Roche confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the Tina-quant C-Reactive Protein Gen. 3 on the cobas c701 and 702 modules. A discoloration…
Class IIFDA: TerminatedRoche Diagnostics Operations, Inc.
Roche has confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the identified products. A discoloration (yellow color) was observed and is the result of…
Class IIIFDA: TerminatedRoche Diagnostics Operations, Inc.
Roche has confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the identified products. A discoloration (yellow color) was observed and is the result of…
Class IIIFDA: TerminatedRoche Diagnostics Operations, Inc.
Potential for Fluid leaks within the instruments, creating an electrical short inside the power socket, which generates heat, smoke, and eventually burning and melting of the electrical…
Class IIFDA: OngoingRoche Diagnostics Operations, Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Roche Diagnostics Operations, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.